Table 2.
AFIF concentration dependently reduced the mean contraction amplitude of PCSMS in different Ca2+ environment (mean ± SD).
| Administration | N | Mean contraction amplitude (%) | ||
|---|---|---|---|---|
| Ca2+-lack | Ca2+-normal | Ca2+-rich | ||
| NS (control) | 10 | 100.03 ± 3.40 | 101.81 ± 3.35 | 97.38 ± 7.35 |
| AFIF, 3 μg/mL | 10 | 98.06 ± 4.97 | 97.60 ± 2.92 | 98.26 ± 6.47 |
| AFIF, 30 μg/mL | 10 | 95.04 ± 11.34 | 95.39 ± 7.71 | 93.92 ± 5.16 |
| AFIF, 300 μg/mL | 10 | 84.47 ± 19.37 | 82.88 ± 19.89 | 81.85 ± 10.32 |
| AFIF, 3000 μg/mL | 10 | 59.96 ± 22.09b | 52.60 ± 17.82b | 70.95 ± 22.02a |
| AFIF, 6000 μg/mL | 10 | 34.15 ± 31.03b | 40.58 ± 18.29b | 47.45 ± 17.39b |
| AFIF, 10000 μg/mL | 10 | 3.96 ± 9.00b | 24.31 ± 16.90b | 34.78 ± 16.33b |
a P < 0.05 and b P < 0.01 versus control.